Table 3.
Multiple Linear Regression Predicting 3-Month BSCVA Correcting for Baseline Visual Acuity and Using Covariates
All Cases With 3-mo Visit | Coefficient (95% CI), logMAR | P Value |
---|---|---|
Treatment arm (corticosteroid vs placebo) | 0.10 (−0.3 to 0.23) | .14 |
Earlier vs later administration of corticosteroid or placebo | −0.02 (−0.13 to 0.10) | .78 |
Interaction between treatment arm and administration time | −0.21 (−0.37 to −0.05) | .01 |
Abbreviation: BSCVA, best spectacle-corrected visual acuity.